Probando

Probando, a trailblazer in the clinical trial market, is dedicated to modernizing patient recruitment, retention, and reimbursement. Founded in Austria in 2020, the company has spearheaded over 300 studies in 20 countries. Using an intelligent, machine learning-based platform, Probando seamlessly links researchers with potential participants, fostering unparalleled efficiency and transparency. As a further asset, ProbandoPay, a web application for patient reimbursement, offers a secure, fast, and global payment platform. Looking ahead, Probando aims to expand its services and create a holistic ecosystem for clinical trials. With a recent Seed Round investment on June 1, 2022, Probando is poised to further revolutionize the industry.